IL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans
about
Mechanistic Insights into the Role of C-Type Lectin Receptor/CARD9 Signaling in Human Antifungal ImmunityThe Host's Reply to Candida BiofilmNeutrophil Attack Triggers Extracellular Trap-Dependent Candida Cell Wall Remodeling and Altered Immune RecognitionTreatment challenges in the management of moderate-to-severe plaque psoriasis - role of secukinumabA Clinician's Guide to the Diagnosis and Treatment of Candidiasis in Patients with PsoriasisImmune Interactions with Pathogenic and Commensal Fungi: A Two-Way StreetCCAAT/Enhancer-binding protein β promotes pathogenesis of EAE.Skin Immunity to Candida albicans.Migratory and adhesive cues controlling innate-like lymphocyte surveillance of the pathogen-exposed surface of the lymph node.Mechanistic rationales for targeting interleukin-17A in spondyloarthritis.The many faces of interleukin-17 in inflammatory skin diseases.The Role of IL-17 in the Pathogenesis of Psoriasis and Update on IL-17 Inhibitors for the Treatment of Plaque Psoriasis.TH9 cells in skin disorders.The Role of Phagocytes and NETs in Dermatophytosis.Mining the oral mycobiome: Methods, components, and meaning.Elucidating the role of hyposalivation and autoimmunity in oral candidiasis.The dichotomous nature of T helper 17 cells.Fungal dysbiosis: immunity and interactions at mucosal barriers.Interleukin 17 Family Cytokines: Signaling Mechanisms, Biological Activities, and Therapeutic Implications.Candida infections and interleukin-17 inhibitors used in dermatology.Pulmonary Interleukin-17-Positive Lymphocytes Increase during Pneumocystis murina Infection but Are Not Required for Clearance of Pneumocystis.IL-17 Receptor Signaling in Oral Epithelial Cells Is Critical for Protection against Oropharyngeal Candidiasis.Total-Body Irradiation Exacerbates Dissemination of Cutaneous Candida Albicans Infection.CD8+ T cells produce a dialyzable antigen-specific activator of dendritic cells.Dectin-1 and Dectin-2 promote control of the fungal pathogen Trichophyton rubrum independently of IL-17 and adaptive immunity in experimental deep dermatophytosis.A novel role for IL-17 in enhancing type 1 helper T cell immunity in the female genital tract following mucosal HSV-2 vaccination.Processing of Candida albicans Ece1p Is Critical for Candidalysin Maturation and Fungal Virulence.Oral epithelial cells orchestrate innate type 17 responses to Candida albicans through the virulence factor candidalysin.Anti-IL-23 and Anti-IL-17 Biologic Agents for the Treatment of Immune-Mediated Inflammatory Conditions.Innate Immunity to Mucosal Candida Infections.Immune Recognition of Fungal Polysaccharides.The Role of IL-17 in Protection against Mucosal Candida Infections.Patient Susceptibility to Candidiasis-A Potential for Adjunctive Immunotherapy.SLA-PGN-primed dendritic cell-based vaccination induces Th17-mediated protective immunity against experimental visceral leishmaniasis: a crucial role of PKCβ.Pathogenic Effects of IFIT2 and Interferon-β during Fatal Systemic Candida albicans Infection.Candida albicans-epithelial interactions and induction of mucosal innate immunity.Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 Inhibition.Candida albicans-Induced Epithelial Damage Mediates Translocation through Intestinal Barriers.Transcriptional Control of Th9 Cells: Role of Foxo1 in Interleukin-9 Induction.Inherited CARD9 Deficiency: Invasive Disease Caused by Ascomycete Fungi in Previously Healthy Children and Adults
P2860
Q26752423-2E454A2A-FFCD-4F1D-B5FF-0181C2DBA27FQ26752938-9CA50E02-2C07-471E-AEB9-A0246F3F6232Q27313707-2EBD43B7-96F4-47BC-A3BA-C5044E0D1E8AQ28069819-95FC978C-DB00-4F55-BD3E-CBDC44486E14Q30248908-F2D5B906-367A-482A-BFFD-CDAE042F036FQ35847333-1BB075F2-E99E-46E1-BBC4-45544186287FQ36249964-E6F9205F-5B43-4BC6-B115-09F4E0796C70Q37062344-2D8C2290-4E3F-454A-910C-1F09188E0FDFQ37245670-FE82F6E8-4BC9-4232-A1CA-08F05C6269A2Q37686009-DCC9E2BC-75B2-44F7-80A7-9E2E95905534Q38818542-75A15E49-A26F-4559-AE3A-F26B8A876A01Q38840275-7D8B425C-A0D4-467C-A19D-4727A6FADD40Q38948052-B9191167-33CC-400B-9C96-DD0F2405EA37Q38962174-DB32674F-67D3-42E1-B161-EC35775380CFQ38993561-32C236F2-1486-489A-B725-E9518319C7A7Q39082425-7CE52E98-9C1F-485F-B13A-320B1B962824Q39337496-3F6771DC-F12C-408D-9E3E-40BC39B36998Q39366659-5B192237-696D-4437-BC3F-EB958A8BC54FQ39376982-91017E70-2E11-41BB-A02E-C1242E89CA4CQ40125170-D6DBDD72-5A6C-4504-8261-1D97E651FC29Q40239285-A098F6A0-C5DE-482B-A6AB-B2AF3ADBA346Q40421383-4C90D60A-3CCD-4BEC-A721-8108DED11F5DQ40515129-0D0735E4-BF35-4BA9-B933-0FDC7B3E779AQ40578625-12306869-CBC5-4DD4-91EB-82CCAB700301Q40670832-91687CA3-35F5-433B-9677-F4DCADDC18AAQ41928855-93A07056-81BB-4CF8-A931-AB30731A3437Q47564420-28EEC266-F687-403C-A794-A48F7518FB19Q47564944-25F3BE43-C4DC-4161-B4A8-D3BECEA5C5CDQ47727612-964E6AA7-823E-4280-8EAC-3D3AB27F5ADCQ48163042-3C22F45B-0BCE-4421-B392-AF1AB61C362CQ48163129-80F8381C-C5CA-4EF3-B9A0-39678A567C91Q49184561-F2AEBA7E-69EC-429D-B215-FA0DD242B80FQ49679946-6D3A5B40-40D2-436A-AE01-2A617EBA8055Q50855811-56BFF9FD-9972-4077-9871-A6349CB5B0DBQ52582152-87BBA5EC-7338-4554-BE94-047755004C8FQ52744189-BB620224-732C-4C0B-A0FB-1837BC3C9786Q53828883-C2799753-69CD-4C48-A981-CC28CA051FE7Q55063292-1F97DCBF-F8FE-4CD8-B654-2371DAEB4B91Q55280345-EE07A43E-C036-44FA-8546-2F43807FBC01Q57059323-BB586632-849C-4672-8BAD-E0E60E6B520F
P2860
IL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
IL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans
@ast
IL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans
@en
IL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans
@nl
type
label
IL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans
@ast
IL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans
@en
IL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans
@nl
prefLabel
IL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans
@ast
IL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans
@en
IL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans
@nl
P2860
P3181
P356
P1476
IL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans
@en
P2093
Heather R Conti
Sarah L Gaffen
P2860
P3181
P356
10.4049/JIMMUNOL.1500909
P407
P577
2015-08-01T00:00:00Z